Triple-negative breast cancer is a particularly aggressive form of the disease that often affects younger women. Unlike other types of breast cancer, it does not respond to hormone therapy, which limits treatment options for many patients. Additionally, immunotherapy is not always a viable choice for those affected. Approximately 70% of patients are unable to receive immunotherapy and must rely on standard chemotherapy, which often has limited effectiveness, according to recent reports.
New method
A significant international study, published in Annals of Oncology, has explored a novel drug called datopotamab deruxtecan. This treatment differs from traditional chemotherapy in its approach. Instead of targeting all rapidly dividing cells, the drug identifies a specific protein found on the surface of cancer cells. Once located, it delivers medication directly into the cell, minimizing damage to healthy tissues.
Researchers have noted that this new treatment is generally better tolerated by patients. While some individuals experienced side effects such as nausea and mouth irritation, fewer patients had to discontinue treatment compared to those undergoing chemotherapy.
Better results
The findings from the study reveal promising outcomes. Patients who received the new treatment lived an average of 10.8 months without their disease worsening. This is nearly twice as long as the 5.6 months observed with chemotherapy. In addition, tumors shrank in 63% of patients treated with the new drug, compared to only 29% with standard treatment.
Overall, the research suggests that this innovative therapy could become a crucial option for patients with triple-negative breast cancer, especially those who are not eligible for immunotherapy. The results highlight the potential of this treatment to improve survival rates and quality of life for those affected.
Other related topics include:
- How orange can affect your body if you drink it every day
- New procedure may help prevent weight regain after Ozempic
- New study: Time in nature may improve the body’s recovery
- Body language mistakes that can hurt first impressions
This breakthrough offers hope for a more targeted and effective treatment approach, potentially changing the landscape of care for patients with this challenging form of breast cancer.
